Alexey Valerevich Polonikov - Epidemiology

Author Information

Alexey Valerevich Polonikov is a distinguished researcher affiliated with the Department of Biology, Medical Genetics and Ecology at Kursk State Medical University, Russia. He also serves at the Laboratory of Statistical Genetics and Bioinformatics at the Research Institute for Genetic and Molecular Epidemiology, within the same university. His research focuses on genetic epidemiology, with particular interest in the genetic factors contributing to multifactorial diseases.

Research Contributions

Alexey Valerevich Polonikov has made significant contributions to the field of genetic epidemiology, particularly in understanding the role of genetic polymorphisms in complex diseases. His recent work includes studies on genetic variations in glutamate cysteine ligase and their contributions to colorectal cancer and ischemic stroke. He has also explored the genetic markers associated with type 2 diabetes mellitus and coronary artery disease, employing comprehensive statistical and bioinformatics analyses to decipher underlying mechanisms.

Aliases

Alexey Valerevich Polonikov is also known by several aliases, including Alexey V Polonikov, A V Polonikov, Alexey Polonikov, Alexey V. Polonikov, and A.v. Polonikov.

Publication and Citation Metrics

Metric	Value
Number of Papers	179
Citation Count	3211
h-index	27

Publications:

Genetic variation at the catalytic subunit of glutamate cysteine ligase contributes to the susceptibility to sporadic colorectal cancer: a pilot study.

DOI: 10.1007/s11033-022-07406-0

Year: 2022

The Impact of Genetic Polymorphisms in Glutamate-Cysteine Ligase, a Key Enzyme of Glutathione Biosynthesis, on Ischemic Stroke Risk and Brain Infarct Size

DOI: 10.3390/life12040602

Year: 2022

Genetic Variation at the Catalytic Subunit of Glutamate Cysteine Ligase Contributes to the Susceptibility to Colorectal Cancer: A Pilot Study

DOI: 10.21203/rs.3.rs-1253021/v1

Year: 2022

Association between RAC1 gene variation, redox homeostasis and type 2 diabetes mellitus.

DOI: 10.1111/eci.13792

Year: 2022

Comprehensive Statistical and Bioinformatics Analysis in the Deciphering of Putative Mechanisms by Which Lipid-Associated GWAS Loci Contribute to Coronary Artery Disease

DOI: 10.3390/biomedicines10020259

Year: 2022

Polymorphism rs1046495 of the GFER Gene as a New Genetic Marker of Preposition to Type 2 Diabetes Mellitus.

DOI: 10.1007/s10517-022-05441-2

Year: 2022

Interrelation of IL1B and IL6 genes polymorphism with blood eosinophilia and histological picture of polyps in patients with chronic polypous rhinosinusitis

DOI: 10.18413/2658-6533-2021-7-4-0-3

Year: 2021

Bioinformatic tools and internet resources for functional annotation of polymorphic loci detected by genome wide association studies of multifactorial diseases (review)

DOI: 10.18413/2658-6533-2020-7-1-0-2

Year: 2021

The Link between Type 2 Diabetes Mellitus and the Polymorphisms of Glutathione-Metabolizing Genes Suggests a New Hypothesis Explaining Disease Initiation and Progression

DOI: 10.3390/life11090886

Year: 2021

Polymorphic variants of glutathione reductase – new genetic markers of predisposition to type 2 diabetes mellitus

DOI: 10.26442/00403660.2021.10.201101

Year: 2021

What are the Challenges of Double Blind?

How Can Epidemiology Inform Health Insurance Policies?

What Types of Data are Used?

What are the Challenges in Implementing Enhanced Education?

How Do Regulatory Agencies Ensure Compliance?

What is the Epidemiological Significance of HLA-DR and DQ Genes?

What are Prophylactic Measures?

What Cleaning Agents are Used?

What is the Role of PAs in Outbreak Investigations?

How Can Epidemiologists and Policymakers Collaborate More Effectively?

Partnered Content Networks

Relevant Topics